New documents published by the Department of Health and Social Care show that Doja Limited were awarded the multi-million pound contract in May of last year. The company’s director has said it was founded to sell “rare diamonds”, and does not appear to have a history of supplying PPE.
The company, which has no website and is registered to an accountant’s firm, was handed the contract under a controversial scheme which allows ministers to directly award deals relating to procurement during the pandemic without putting the tender to a competitive process.
Dido Harding’s Test and Trace system is splashing out nearly a million pounds every day to private consultancy firm Deloitte, newly-released government figures have revealed.
David William’s, a top-ranking civil servant at the Department of Health and Social Care (DHSC), told MPs on Monday that 900 of the firm’s consultants were currently employed – at a rate of £1,000 per day.
The disclosure of the astonishing level of expenditure comes after parliamentarians were told that DHSC expected to spend £15 billion on coronavirus in the next three months on testing alone – particularly the rollout of controversial rapid testing – to tackle the pandemic.
Ivor Cummins aka the Fat Emperor – gives James the lowdown on why you can’t trust anything our governments tell us about Covid-19. If you want the facts on Coronavirus – how deadly is it? do lockdowns and masks work? how does it compare with previous pandemics? – you’ve come to the right place
Please support the Delingpod:
Mirror archives are available below if this video is removed from YouTube.
The unprecedented measures of universal lockdowns, tight institutional lockdowns of care homes, universal masking of the general population, obsession with surfaces and hands, and the accelerated vaccine deployment are contrary to known science, and contrary to recent leading studies. There has been government recklessness by action and negligence by omission. Institutional measures have been needed for a long time to stem corruption in both medicine and public health policy.
This hunger games scenario of a middle-aged, potentially pre-infected and already immune health secretary taking a nominal, rushed, improperly trialled novel-technology vaccine after the pandemic has already passed on live TV is as unethical and obscene as any of the propaganda we have been subjected to. What have we become? If it happens, the supposed vaccinator, the TV station, the secretary of state, and the vaccine company should all be roundly condemned. It proves nothing and risks everything. Obnoxious and dangerous as he is, he hasn’t a clue what might happen to him. He is still that sacred thing: somebody’s patient. A power-crazed, ignorant man for whom the mantras “whatever it takes” and the “end justifies the means” are dear, offering himself for a macabre, televised ritual sacrifice fit for the Incas to appease his political masters. It is truly grotesque. There is no medical reason for him to have these chemicals.
- Professor Chris Whitty is paid between £205,000 and £210,000, it was revealed
- Meanwhile the chief scientific adviser Sir Patrick Vallance is on up to £185,000
- Thirty officials at soon-to-be scrapped Public Health England earn more than £150,000
England’s test and trace service is being sub-contracted to a myriad of private companies employing inexperienced contact tracers under pressure to meet targets, a Guardian investigation has found.
Under a complex system, firms are being paid to carry out work under the government’s £22bn test and trace programme. Serco, the outsourcing firm, is being paid up to £400m for its work on test and trace, but it has subcontracted a bulk of contact tracing to 21 other companies.
Contact tracersworking for these companiestold the Guardian they had received little training, with one saying they were doing sensitive work while sitting beside colleagues making sales calls for gambling websites.
Little is known about the interests of the doctors, scientists, and academics on whose advice the UK government relies to manage the pandemic. Attempts to discover more are frequently thwarted, finds Paul D Thacker.
Randomised control trial study showing safety and efficacy of COVID-19 vaccine has clear conflicts of interest.
The Cabinet Office signed the lucrative contract with London-based OMD Group as the Government began to gear up its response to the crisis.
Ministers struck a deal worth up to £119m with one of the world’s biggest marketing companies for a Covid campaign three weeks before the country went into a national lockdown, official filings show.
This week, the government promised a total of £1 billion in financial support to local authorities under the new three-tier lockdown system. Areas subjected to Tier 2 lockdowns will be granted £1 per head of the population, and £2 per head for Tier 3. Meanwhile, £30million has been earmarked for local authorities to pay for Covid marshals and other ‘compliance and enforcement’ activities.
Recently, the Government agreed a £161 million deal with a British company called DnaNudge to provide 5.8 million Covid tests, as part of its “Moonshot” programme for mass testing of the population at the point of care. The CovidNudge test is “a rapid, accurate, portable and lab-free RT-PCR test that delivers results at the point of need and in just over an hour”, according to DnaNudge’s own promotional material. DnaNudge is a spinoff company of Imperial College London.
Care home chiefs fear deadly mistakes made at the peak of the coronavirus pandemic risk being repeated as councils offer them extra cash to take Covid-positive hospital patients.
…Now, despite a Government pledge to place a ‘protective ring’ around vulnerable residents, care homes in Cumbria are being offered £1,500 – double the local weekly fee – to take Covid-positive patients from hospital.
…Tony Carling, a care home operator in Cumbria, has decided not to take Covid-positive patients, but fears it could be a costly move. He said: ‘The majority of our clients are funded by local authorities, so it’s very difficult to turn down. You are under extreme financial pressure as to whether you get further business from that authority if you don’t support their needs.’
The UK’s chief scientific adviser has a £600,000 shareholding in a drugs giant contracted to develop a Covid-19 vaccine for the Government, prompting claims of a potential conflict of interest.
- Sir Patrick Vallance, Chief Scientific Adviser to UK Government, was president of GSK 2012 – 2018
- Holds a deferred bonus of 43,111 shares worth £600,000
- Cashed in more than £5m worth of shares upon resignation of GSK
- Sir Vallance special board on vaccines
- From late-February 2020, Birmingham City Council gave care homes a £1,000 extra cash to take in hospital patients in a hurry, including some with coronavirus.
- Reason: more NHS beds could be freed up for coronavirus patients.
- Care home had to bid for the resident in a four hour window and, if their bid was ‘winning’, organise admission within 24 hours – regardless of the citizen’s Covid-19 testing or diagnosis status at the point of discharge.
- Care home manager, Jane Farr, of Digby Manor care home in Erdington, believes her rejection of the offer is one of the reasons none of her residents have been infected.
- From late February, any in-patients deemed ‘fit to discharge’ were rapidly moved out of hospital so hospital staff could focus on coronavirus patients.
- Dr David Rosser, chief executive of University Hospitals Birmingham (UHB) said the city created too much capacity – indicating some of the frantic measures to empty beds turned out to be not needed.
- From April 15 the Government’s rules changed and all discharged residents were supposed to undergo a test first.
The Recovery trial has steadfastly ignored Professor Didier Raoult and a string of countries that have implemented his protocol, early use of HCQ with Azythromycin in safe doses, despite the fact that, after treating 3,737 patients — the single largest study in the world —Raoult has lost only 0.6 per cent, while Horby and Landray are presiding over carnage —a fatality rate of 25 per cent.
- The Recovery trial has steadfastly ignored Professor Didier Raoult in the early use of HCQ with Azythromycin in safe doses.
- Raoult has lost only 0.6 per cent, while Horby and Landray are presiding over carnage —a fatality rate of 25 per cent.
- Landray admitted to an investigative journalist at FranceSoir ‘these are quite high doses to… have a chance of killing the virus.’ Or killing the patient.
- Recovery is not the only trial delivering dangerously elevated doses of HCQ to Covid patients. Dosage in the international Solidarity trial was four times greater than the dose being used in India.
- WHO has been working for years with Gilead Sciences trying to get the pharmaceutical company’s lacklustre drug Remdesivir to show efficacy at curing first Ebola, with poor results, and now Covid-19.
- Landray revealed Gilead pays scientists 20 to 50 times more to conduct a clinical trial than Horby and Landray were paid to conduct the Recovery trial.
- Horby is the executive director of the International Severe Acute Respiratory and Emerging Infection Consortium which received 4.5 million pounds for research into vaccines.
- Horby established the Epidemic Research Group which is promised up to 14 million pounds from AstraZeneca and Zuckerberg/Chan of Facebook fame for the development of a Covid-19 vaccine which is being trialled by Oxford University.
- AstraZeneca is interested in merging with Gilead Sciences, which, if it went through, would create the biggest Big Pharma ever.
- Horby and Landray have announced that dexamethasone, a low-cost steroid which is also being tested has reduced the mortality rate of Covid-19 patients on ventilators from a scandalous 41 per cent to a still appalling 32 per cent.
- Raoult has pointed out that in his hospital, of the 0.6 per cent who die, a mere 16 per cent were in ICU
- In Britain, where almost 42,000 people have died of Covid, the only thing randomised, controlled trials have achieved, is to blind people to the evidence that 40,000 of those deaths could have been avoided.
- Non-COVID patients were put in with COVID patients, then marked with Do Not Resuscitate orders.
- Hospitals have a financial incentive to mark patients as COVID-19.
- Doctors stopped treating people as humans. Inexperienced doctors were practicing on patients.
- COVID-19 has been proven to be easily treatable with the Hydroxychloroquine/Zinc/Antibiotic protocol
- People were coming in too late due to fear.
- Patients were unnecessarily put on ventilators. “They want to use the vents.”
- Patients were put in restraints “due to laziness.”
- New York may have been hit hard because their hospitals were already struggling. They couldn’t afford to keep them open.
A healthcare firm which employs the prominent Conservative politician Owen Paterson as a paid consultant has been awarded a £133m contract without any other firms being given the opportunity to bid for the work.
The Department of Health and Social Care (DHSC) has given Randox the contract to produce testing kits to help respond to the coronavirus pandemic. It was awarded “without prior publication of a call for competition”, according to details of the contract seen by the Guardian.
Letter dated 17 March 2020 to Chief executives of all NHS trusts and foundation trusts.
ANNEX: CORONAVIRUS COST REIMBURSEMENT
This guidance sets out the amended financial arrangements for the NHS for the period between 1 April and 31 July. These changes will enable the NHS and partner organisations (including Local Authorities and the Independent Sector) to respond to COVID-19. We will continue to revise this guidance to reflect operational changes and feedback from the service as the response develops.
We will shortly be making a payment on account to all acute and ambulance providers to cover the costs of COVID-19-related work done so far this year, with final costs for the current financial year being confirmed as part of the year end processes. This initial
payment will be based on information already submitted by providers. Future payments will be based on further cost submissions.
All NHS providers and commissioners must carefully record the costs incurred in responding to the outbreak and will be required to report actual costs incurred on a monthly basis. Accurate record keeping during this time is crucial – record keeping must meet the requirements of external audit, and public and Parliamentary scrutiny.
To support reimbursement and track expenditure we will in due course be asking all relevant organisations to provide best estimates of expected costs from now until the expected end of the peak outbreak. We will provide further guidance with relevant
assumptions in order to support you in making these estimates.